ABBV

NYSE · Biotechnology

Abbvie Inc

S&P 500 Mega-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield

$207.18

+1.98 (+0.96%)

As of Mar 25, 9:30 PM ET ·

Analyst Consensus

Buy

Analysts

Very High

Coverage

Buy 27 69%

Hold 12 31%

Sell 0 0%

Price Target

Analyst Price Target +24.3% upside

Low Target $173.19

Average Target $257.58

High Target $337.66

Current Price $207.18

Current
$207.18

Target
$257.58

$173.19 $257.58 avg $337.66

Scenario Analysis

Bear Case

$173.19

-16.4%

Low target

Base Case

$257.58

+24.3%

Avg target

Bull Case

$337.66

+63.0%

High target

Risk/Reward

3.8x

Highly favorable

Price in Context

52-Week High

$244.81

-15.4% from high

52-Week Low

$164.39

+26.0% from low

50-Day SMA

$223.82

-7.4% vs SMA

200-Day SMA

$211.12

-1.9% vs SMA

RSI (14)

54.5

Neutral

Target vs 52W High

$257.58

+5.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%